INRLF
Price:
$2.58
Market Cap:
$432.20M
Valneva SE operates as a specialized biopharmaceutical entity, primarily focused on the creation and commercialization of preventative vaccines for infectious diseases where effective treatments are currently lacking. Its existing range of vaccines for international travelers includes IXIARO, an inactivated, Vero cell culture-based immunization designed to actively protect against Japanese encephalitis. Another key product is DUKORAL, an oral vaccine intended to prevent diarrhea caused by Vibrio cholera and/or the heat-labile toxin-producing Enterotoxigenic Escherichia coli. The company also developed VLA2001, a vaccine candidate targeting SARS-CoV-2. In its development pipeline, Valneva is ...[Read more]
Industry
Biotechnology
IPO Date
2010-04-23
Stock Exchange
OTC
Ticker
INRLF
According to Valneva SE’s latest financial reports and current stock price. The company's current ROE is -106.22%. This represents a change of 240.95% compared to the average of -31.16% of the last 4 quarters.
The mean historical ROE of Valneva SE over the last ten years is -44.63%. The current -106.22% ROE has changed 138.01% with respect to the historical average. Over the past ten years (40 quarters), INRLF's ROE was at its highest in in the December 2021 quarter at 101.13%. The ROE was at its lowest in in the June 2022 quarter at -155.97%.
Average
-44.63%
Median
-46.10%
Minimum
-108.50%
Maximum
2.28%
Discovering the peaks and valleys of Valneva SE ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.35%
Maximum Annual ROE = 2.28%
Minimum Annual Increase = -156.61%
Minimum Annual ROE = -108.50%
| Year | ROE | Change |
|---|---|---|
| 2025 | -108.50% | 1.51% |
| 2024 | -6.76% | -91.46% |
| 2023 | -79.09% | 21.33% |
| 2022 | -65.19% | 51.44% |
| 2021 | -43.04% | -48.25% |
| 2020 | -83.17% | 6.35% |
| 2019 | -1.29% | -156.61% |
| 2018 | 2.28% | -118.40% |
| 2017 | -12.39% | -74.80% |
| 2016 | -49.16% | 244.15% |
The current ROE of Valneva SE (INRLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-64.78%
5-year avg
-60.52%
10-year avg
-44.63%
Valneva SE’s ROE is less than Idorsia Ltd (19.23%), less than Basilea Pharmaceutica AG (27.95%), greater than Veradigm Inc. (-7.13%), less than Safilo Group S.p.A. (12.37%), less than Viva Biotech Holdings (5.57%), less than MedinCell S.A. (84.89%), greater than Nxera Pharma Co., Ltd. (-15.58%), less than EL.En. S.p.A. (16.99%), less than GenSight Biologics S.A. (42.20%), greater than Avacta Group Plc (-2929.47%),
| Company | ROE | Market cap |
|---|---|---|
| 19.23% | $1.47B | |
| 27.95% | $746.00M | |
| -7.13% | $815.18M | |
| 12.37% | $789.95M | |
| 5.57% | $284.79M | |
| 84.89% | $1.23B | |
| -15.58% | $567.36M | |
| 16.99% | $1.48B | |
| 42.20% | $30.99M | |
| -2929.47% | $454.97M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Valneva SE using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Valneva SE or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Valneva SE's ROE?
How is the ROE calculated for Valneva SE (INRLF)?
What is the highest ROE for Valneva SE (INRLF)?
What is the 3-year average ROE for Valneva SE (INRLF)?
What is the 5-year average ROE for Valneva SE (INRLF)?
How does the current ROE for Valneva SE (INRLF) compare to its historical average?